Abstract
Purpose
To localize and quantify ischemic changes induced by proton beam irradiation of central choroidal melanoma and to identify baseline predictors correlated with the extent of ischemic changes.
Methods
Retrospective chart review of patients with central choroidal melanoma treated by proton beam irradiation and conducted widefield fluorescein angiography (≥ 20 months after radiation therapy). Quantification and location of ischemic areas and correlation to baseline predictors. Multiple linear regression model was performed for analyses.
Results
Twenty-five eyes from 25 patients were included in final analysis. Mean largest basal tumor area was 56.6 ± 40.0 mm2 and mean maximal tumor prominence 2.5 ± 1.4 mm. Mean total radiated area was 339.1 ± 68.3 mm2. All patients showed ischemic changes. Mean ischemic area was 387.6 ± 123.3 mm2 and mean ischemic index (ischemic area/total visible area) was 0.53 ± 0.23. Twenty-two patients (88%) presented ischemic changes outside of the irradiation field, which comprised of 23% of total ischemic area. Mean angular distance between lateral border of irradiation field and ischemic area outside of the radiated area was 44.8 ± 36.5°. Multivariable analysis revealed a positive correlation of total ischemic area with total radiated area (p = 0.02) and initial sonographic tumor prominence (p = 0.02).
Conclusions
Ischemic changes induced by proton beam irradiation of central choroidal melanoma were localized and quantified. Ischemic changes exceed the tumor area distinctly and are found also outside of the irradiation field in the majority of patients. Size of irradiation area and tumor prominence are positively correlated with extent of ischemic area.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Seibel I, Cordini D, Hager A, Tillner J, Riechardt AI, Heufelder J, Davids AM, Rehak M, Joussen AM (2016) Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 254:1787–1792. https://doi.org/10.1007/s00417-016-3429-4
Seibel I, Riechardt AI, Heufelder J, Cordini D, Joussen AM (2017) Adjuvant ab interno tumor treatment after proton beam irradiation. Am J Ophthalmol 178:94–100. https://doi.org/10.1016/j.ajo.2017.03.027
Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW (1999) Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 117:609–614
Sagoo MS, Shields CL, Emrich J, Mashayekhi A, Komarnicky L, Shields JA (2014) Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases. JAMA Ophthalmol 132:697–702. https://doi.org/10.1001/jamaophthalmol.2014.111
Heufelder J, Cordini D, Fuchs H, Heese J, Homeyer H, Kluge H, Morgenstern H, Hocht S, Nausner M, Bechrakis NE, Hinkelbein W, Foerster MH (2004) Five years of proton therapy of eye neoplasms at the Hahn-Meitner Institute, Berlin. Z Med Phys 14:64–71
Dobler B, Bendl R (2002) Precise modelling of the eye for proton therapy of intra-ocular tumours. Phys Med Biol 47:593–613
Pfeiffer K, Bendl R (2001) Real-time dose calculation and visualization for the proton therapy of ocular tumours. Phys Med Biol 46:671–686
Singer M, Sagong M, van Hemert J, Kuehlewein L, Bell D, Sadda SR (2016) Ultra-widefield imaging of the peripheral retinal vasculature in normal subjects. Ophthalmology 123:1053–1059. https://doi.org/10.1016/j.ophtha.2016.01.022
Patel RD, Messner LV, Teitelbaum B, Michel KA, Hariprasad SM (2013) Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema. Am J Ophthalmol 155:1038–1044 e1032. https://doi.org/10.1016/j.ajo.2013.01.007
Pena LA, Fuks Z, Kolesnick RN (2000) Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60:321–327
Shah AR, Abbey AM, Yonekawa Y, Khandan S, Wolfe JD, Trese MT, Williams GA, Capone A Jr (2016) Widefield fluorescein angiography in patients without peripheral disease: a study of normal peripheral findings. Retina 36:1087–1092. https://doi.org/10.1097/IAE.0000000000000878
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent
For this type of study, formal consent is not required.
Proprietary interest
All authors declare to have no proprietary interest.
Financial disclosures
C.B.: payment for development of educational presentations (Pharm-Allergan GmbH, Frankfurt am Main, Germany); I.S.: payment for development of educational presentations (Novartis Pharma GmbH, Nürnberg, Germany, Pharm-Allergan GmbH, Frankfurt am Main, Germany, Bayer AG, Leverkusen, Germany); J.H.: none, A.M.J.: payment for development of educational presentations (Novartis Pharma GmbH, Nürnberg, Germany) and travel/accommodations/meeting expenses (Novartis Pharma GmbH, Nürnberg, Germany, Alcon Pharma GmbH Freiburg im Breisgau, Germany, and Pharm-Allergan GmbH, Frankfurt am Main, Germany).
Rights and permissions
About this article
Cite this article
Busch, C., Löwen, J., Pilger, D. et al. Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma. Graefes Arch Clin Exp Ophthalmol 256, 1599–1604 (2018). https://doi.org/10.1007/s00417-018-4036-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-018-4036-3